INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Mankind Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543904	ISIN Demat INE634S01028	Book Value 334.17	NSE Symbol MANKIND	Dividend Yield (%) 0	Market Cap (₹ Cr.) 97,009.59	P/E 50.17	EPS 46.87	Face Value 1

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	9,264.81	8,127.15	7,486.22	5,523.18	4,794.41
Sale of Products	9,218.55	8,082.54	7,448.21	5,388.89	4,651.89
Sale of Services	45.11	38.04	38.01	97.27	78.26
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	1.15	6.58	0.00	37.02	64.26
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	9,264.81	8,127.15	7,486.22	5,523.18	4,794.41
Other Income	266.64	162.78	203.81	154.50	93.85
Total Revenue	9,531.45	8,289.94	7,690.04	5,677.68	4,888.26
Changes in Inventories	-25.36	267.89	-365.27	-254.25	-44.51
Cost of Material Consumed	861.74	711.05	772.59	494.53	434.87
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	2,071.92	1,865.82	2,114.12	1,541.89	1,182.55
Employee Benefits	1,982.10	1,701.38	1,462.76	1,167.42	991.47
Total Other Expenses	2,049.30	1,883.64	1,663.95	1,201.72	986.57
Manufacturing / Operating Expenses	213.57	175.62	153.93	103.86	104.22
Administrative and Selling Expenses	1,699.55	1,539.07	1,378.52	905.53	696.80
Other Expenses	136.18	168.95	131.50	192.32	185.55
Finance Costs	14.57	27.75	47.12	7.98	10.62
Depreciation and Amortization	317.61	269.58	123.33	78.19	61.77
Total Expenses	7,271.88	6,727.10	5,818.60	4,237.47	3,623.34
Profit Before Exceptional Items and Tax	2,259.57	1,562.84	1,871.44	1,440.21	1,264.92
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	2,259.57	1,562.84	1,871.44	1,440.21	1,264.92
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	2,259.57	1,562.84	1,871.44	1,440.21	1,264.92
Taxation	436.16	314.58	482.01	355.83	306.70
Current Tax	415.39	296.00	429.03	346.99	336.58
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	24.18	30.30	52.98	8.84	-35.11
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	-3.41	-11.72	0.00	0.00	5.23
Profit After Tax	1,823.41	1,248.26	1,389.42	1,084.37	958.23
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	1,823.41	1,248.26	1,389.42	1,084.37	958.23
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	1,823.41	1,248.26	1,389.42	1,084.37	958.23
Earning Per Share - Basic	45.52	31.16	34.68	27.07	23.92
Earning Per Share - Diluted	45.45	31.16	34.68	27.07	23.92
Operation Profit before Depreciation	2,591.74	1,860.16	2,041.89	1,526.37	1,337.31
Operating Profit after Depreciation	2,274.14	1,590.58	1,918.56	1,448.19	1,275.54
Dividend Per Share	0.00	0.00	0.00	0.00	7.55
Dividend Percentage	0.00	0.00	0.00	0.00	755.00
Equity Dividend	0.00	0.00	0.00	0.00	302.44
Weighted Average Shares - Basic	40.06	40.06	40.06	40.06	40.06
Weighted Average Shares - Diluted	40.12	40.06	40.06	40.06	40.06